Different methods of ventricular fibrillation threshold determination reflect distinct electrophysiological properties, highlighting the varying mechanisms of class IC and class III antiarrhythmic drugs.
Animal VFT data warrant caution before clinical extrapolation; leaves open optimal methods for assessing antiarrhythmic mechanisms.
No takes yet. Share an insight, caveat, or question.
Masahiro Usui (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: